Executive Profile*

Brian Schwartz M.D.

This person is connected to 0 board members in 0 different organizations across 2 different industries.

52

$663,919As of Fiscal Year 2013

Background*

Dr. Brian Schwartz, MD has been the Chief Medical Officer and Senior Vice President of Clinical and Regulatory Affairs for ArQule Inc. since July 14, 2008. Dr. Schwartz served as Senior Vice President of Medical & Regulatory Affairs and Chief Medical Officer of Ziopharm Oncology, Inc. from June 1, 2006 to July 11, 2008. He has extensive regulatory experience in working with the U.S. Food and Drug Administration Oncology Division, the European Medicines Evaluation Agency, ... (EMEA) and numerous other health authorities. Most recently, he was responsible for U.S. clinical and regulatory activities, including phase IV studies and interactions with the National Cancer Institute and other oncology cooperative groups. Dr. Schwartz has extensive experience in working with Scientific Advisory Boards, international project teams, and in leading joint development projects with biotechnology companies. He has impressive drug development registration experience in the pharmaceutical industry with both Bayer Healthcare and Leo Laboratories. At Bayer, Dr. Schwartz was the key Physician and was responsible for the global clinical development of sorafenib (Nexavar(R)) and led the clinical team through a successful phase III trial in renal cell cancer, leading to Food and Drug Administration (FDA) approval since December 20, 2005. Over eight years, he focused on oncology clinical development of novel cytostatic, cytotoxic and immunological agents, achieving Awards for Excellence from both employers. He practiced medicine and worked at the University of Toronto before joining Leo Laboratories Canada. Dr. Schwartz received his Medical Degree from the University of Pretoria, South Africa.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.